Vaishali Pharma will take over domestic and international marketing operations of Sankalp Life Care, agreement signed between the two companies

April 20, 2022 23:30 IST | ANI Press Release
Tennis player James Blake
Mr. Atul Vasani, Managing Director - Vaishali Pharma Ltd.

Ahmedabad (Gujarat) [India], April 20 (ANI/PNN): Ahmedabad-based Sankalp Life Care, a leading manufacturer of nutraceuticals, and Mumbai-headquartered Vaishali Pharma Ltd., a leading manufacturer and exporter of pharma formulations, have come together to form a unique partnership that will help both companies grow faster.

As per the agreement between the two companies, NSE-listed Vaishali Pharma Ltd. will take over the entire domestic and international marketing of Sankalp Life Care's portfolio of nutraceutical products.

"This is a perfect partnership. Sankalp Life Care's core strength is in manufacturing the best quality nutraceutical products, and Vaishali Pharma has a wide global presence in the Indian and multiple markets and specializes in marketing. The partnership will allow us to leverage Vaishali Pharma's marketing reach and focus on our expertise. It is a win-win for both companies, and we look forward to growing together and offering the highest-quality nutraceutical products to customers in India and around the world," said Dimple Goenka, Director, Sankalp Life Care.

"This agreement between Vaishali Pharma and Sankalp Life Care is the first-of-its-kind in the Indian Pharma Industry. Vaishali Pharma will handle the complete domestic and international marketing operations of Sankalp Life Care and make Sankalp Life Care's 100+ innovative products available in more than 40 countries. The unique agreement builds on the strengths of the two companies and will be mutually beneficial," said Atul Vasani, Managing Director, Vaishali Pharma Ltd.

Sankalp Life Care is a leading nutraceuticals company and has set up the 5th largest nutraceuticals facility in the country at Bavla, Ahmedabad. A range of tablets, capsules, powders, sachets, gummies, liquid and effervescent tablets, among other products, are made at the zero-discharge facility, which is fully operational now and has been designed as per standards defined by World Health Organisation. It is also designed as per USFDA standards, and the company has already made an application for USFDA approval for the facility.

Vaishali Pharma, which manufactures and exports pharma formulations in a wide spectrum of dosage forms & therapeutic segments, Active Pharmaceutical Ingredients (APIs), surgical products, nutraceutical, and oncology products, is one of the fastest-growing and most versatile companies in the industry. It has a strong presence in both the domestic and export markets and is currently a supplier to all leading Indian and multinational pharmaceutical companies. The company has been catering to semi-regulated and non-regulated markets across the globe.


This story is provided by PNN. ANI will not be responsible in any way for the content of this article. (ANI/PNN)


(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)


Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor